Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Coronary Artery Disease I: Introduction
Atherosclerosis IV: Nursing Management
Drug Toxicity: Risk factors
Cancer Prevention
Venous Thrombosis III: Interprofessional Care
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 8, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Amelia K Boehme1, Charles Esenwa1, Mitchell S V Elkind2
1From the Department of Epidemiology, Mailman School of Public Health (A.K.B., M.S.V.E.) and Department of Neurology, College of Physicians and Surgeons (A.K.B., C.E., M.S.V.E.), Columbia University, New York, NY.
Understanding stroke risk factors, both nonmodifiable and modifiable, is key to prevention. Recent research highlights genetic factors and environmental interactions, offering new avenues for targeted stroke prevention strategies.
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: